Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-15

FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for ESTRING (estradiol) from Pfizer Laboratories, updating labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRING (Estradiol)

Snippet

SUPPL AP for ESTRING (ESTRADIOL)